ScholarIQanswers from OpenAlex

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma

PaperCitations, authors & open-access status

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma have?

ScholarIQcitation count

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma has 152 citations in the OpenAlex counts ScholarIQ stores.

When was Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma published?

ScholarIQyear

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma has 2018 year in the ScholarIQ index.

What is the open-access status of Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma?

ScholarIQoa status

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma has closed oa status in the ScholarIQ index.

What is the DOI of Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma?

ScholarIQdoi

The DOI for Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma is on the source record.

What is the PMID of Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma?

ScholarIQpmid

The PMID for Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma is on the source record.

What is the OpenAlex record for Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma?

ScholarIQopenalex

The OpenAlex for Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial